Drug Development, Precision Medicine and the Case for Machine Learning
- Oct 03 2019
11:00 am - 2:30 pm EST
- Salt Creek Grille
One Rockingham Row
Princeton, NJ 08540
Drug Development, Precision Medicine and the Case for ML
The data revolution in the pharmaceutical and biopharmaceutical industries has given way to a new order for R&D and clinical trials. Today, it is expected that firms will employ big data analytics and artificial intelligence (AI) to improve processes for drug discovery, development, and approval. Firms that are not there yet are playing catch up.
Industry thought-leader, Forbes contributing healthcare author, and former presidential adviser, John E. Osborn, will share his unique insights and views on ML and AI for Life Sciences, where ML and AI can really make a positive impact on your success, and where to get started on your journey from data to knowledge to wisdom.
Limited seating. Please RSVP today!
John E. Osborn
Former Life Sciences Executive and Board Member
JOHN E. OSBORN has been a life sciences industry executive, board member, lawyer, lecturer, writer and diplomat. He currently works as a senior advisor with the international law firm Hogan Lovells, and he also has been a healthcare industry advisor with Warburg Pincus, and a board member of publicly traded and privately held companies in the specialty pharmaceutical, healthcare IT and biomedical device sectors. For more than twenty years, John was a senior executive and general counsel with notable life sciences and healthcare companies, including Cephalon, US Oncology, Onyx Pharmaceuticals and Dendreon.
Ellen M. Derrico
VP, Health and Life Sciences, SpringML
ELLEN M. DERRICO is an executive with over 30 years of experience in healthcare, life sciences, and technology companies. Her career spans leadership roles in marketing, sales, market development, R&D, clinical, and consulting. She has worked with companies ranging from startup to multi-billion dollar revenue conglomerates. Former companies and clients include: IQVIA, Salesforce.com, Hewlett Packard/Agilent, SAP, TriPath Imaging (Becton Dickenson), G.D. Searle (Pfizer), Emergent Biosolutions, Fast Track Systems (Medidata Solutions).
Networking and Registration
Opening Remarks by Charles Landry, CEO, SpringML
11:45 am-12:30 pm
Keynote Presentation by John E. Osborn: Drug Development, Precision Medicine and the Case for ML
Presentation by Ellen M. Derrico, SpringML: Entering a New Age of Innovation and Productivity in R&D and Clinical
Wrapup and Networking